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Summary
Forkhead Box P3 (Foxp3)-expressing regulatory T (Treg) cells are central to maintaining self-
tolerance and immune homeostasis. How Treg cell function and Foxp3 expression are regulated is
an important question under intensive investigation. Here, we have demonstrated an essential role
for the transcription factor GATA-3, a previously recognized Th2 cell master regulator, in
controlling Treg cell function. Treg cell-specific GATA-3 deletion led to a spontaneous
inflammatory disorder in mice. GATA-3-null Treg cells were defective in peripheral homeostasis
and suppressive function, gained Th17 cell phenotypes and expressed reduced amounts of Foxp3.
In addition, GATA-3 controlled Foxp3 expression by binding to and promoting the activity of cis-
acting elements of Foxp3. Furthermore, the combined function of GATA-3 and Foxp3 was
essential for Foxp3 expression. These findings provide insights into immune regulatory
mechanisms and uncover a critical function of GATA-3 in Treg cells and immune tolerance.
Introduction
Regulatory T (Treg) cells are a CD4+ T cell subset possessing potent immune suppressive
activities critical for maintaining self-tolerance and immune homeostasis. Defects in Treg
cell function invariably result in autoimmunity and inflammatory disease in mammals
(Sakaguchi et al., 2008; Shevach, 2000). Foxp3, an X-linked transcription factor, is highly
and specifically expressed in Treg cells. Ectopic expression of Foxp3 endows non-Treg cells
with immune-suppressive function (Brunkow et al., 2001; Khattri et al., 2003), and Foxp3
deficiency leads to systemic autoimmune syndrome in human IPEX patients and Scurfy mice
due to lack of functional Treg cells (Brunkow et al., 2001; Fontenot et al., 2003; Hori et al.,
2003; Wildin et al., 2001). Therefore, Foxp3 is recognized as the central regulator of Treg
cells. To understand immune tolerance and immune homeostasis, how Treg cell and Foxp3
function are controlled is a critical question yet to be fully addressed. Increasing numbers of
transcription factors are shown to be important for Treg cell function (Chaudhry et al., 2009;
Kerdiles et al., 2010; Kitoh et al., 2009; Koch et al., 2009; Ouyang et al., 2010; Rudra et al.,
2009; Zheng et al., 2009). Curiously, factors controlling the differentiation of Th1 and Th2
cells regulate distinct and specific functions of Treg cells (Kitoh et al., 2009; Koch et al.,
2009; Rudra et al., 2009; Szabo et al., 2000; Zheng et al., 2009)}.
Correspondence should be addressed to Y.Y.W: 919-966-9728 (phone), 919-966-3015 (fax), wany@email.unc.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Immunity. Author manuscript; available in PMC 2012 September 23.
Published in final edited form as:













GATA-3 is a transcription factor that is highly expressed in Th2 cells and critical for the
differentiation of these cells (Zheng and Flavell, 1997; Zhu et al., 2004). GATA-3 is
therefore regarded as the “master regulator” for Th2 cells. Nevertheless, GATA-3
expression and function is not limited to Th2 cells. GATA-3 is expressed in multiple tissues
and cell types (Yamamoto et al., 1990) and is required for T cell development and natural
killer (NK) cell function (Pai et al., 2003; Samson et al., 2003). Thus, GATA-3 plays multi-
faceted roles of regulating immune function in a cell-type specific fashion. Importantly,
whether and how GATA-3 is involved in controlling Treg cell function in vivo is unknown.
We found that GATA-3 expression was elevated in Treg cells compared to conventional T
cells and was suppressed in Treg cells under Th1 cell polarizing condition, where Treg cell
function is often found tempered (Caretto et al., 2010; Oldenhove et al., 2009). We therefore
hypothesized that GATA-3 expression in Treg cells is important for their optimal function
and that defective GATA-3 expression will alter the properties of Treg cells. To test this
hypothesis, we deleted GATA-3 specifically in Foxp3-expressing Treg cells and found that
GATA-3 deletion in Treg cells led to the development of an inflammatory disorder in mice.
GATA-3-deficient Treg cells were intrinsically defective in their homeostasis and showed
compromised immune suppressive function in vitro and in vivo. In agreement with these
observations, GATA-3-deficient Treg cells expressed decreased amounts of Foxp3 and Treg
cell “signature genes” and increased amounts of effector cytokines. In addition, we
demonstrated that GATA-3 bound to the regulatory region of Foxp3 locus and promoted the
activity of a cis-acting element of Foxp3 gene. Moreover, we showed that the combined
function of GATA-3 and Foxp3 was vital for Foxp3 expression, because virtually no Foxp3-
expressing cells could be detected when both GATA-3 and Foxp3 were defective.
Collectively, this study reveals an essential function of GATA-3 in controlling Treg cell
function and Foxp3 expression. It provides further insight into immune regulatory
mechanisms and sheds lights on GATA-3 function and how immune responses are
controlled.
Results
1. Mice with Treg cell-specific GATA-3 deletion develop an inflammatory disorder
Transcription factors critically involved in directing the differentiation of Th1 and Th2 cells
were recently shown to play unique and important roles in controlling Treg cell function
(Kitoh et al., 2009; Koch et al., 2009; Rudra et al., 2009; Zheng et al., 2009). However,
whether the Th2 cell master regulator GATA-3 is involved in Treg cell function remains
unknown. To address this question, we first asked if GATA-3 is expressed by Treg cells.
GATA-3 expression was assessed in purified Treg cells and non-Treg CD4+ T (Tn) cells
isolated from FIR mice, where Foxp3-expressing cells were marked by the expression of a
red fluorescence protein, as described previously (Wan and Flavell, 2005). Treg cells
expressed more GATA-3 than Tn cells at both mRNA and protein levels. In addition,
GATA-3 expression was down-regulated in Treg cells under Th1 cell polarizing condition
associating with reduced Treg cell recovery and Foxp3 expression (Supplementary Fig. S1),
agreeing with the finding that Treg cell function is tempered during Th1 response (Caretto et
al., 2010; Oldenhove et al., 2009). These observations suggest a potential role of GATA-3 in
regulating Treg cell function. We therefore investigated how GATA-3 is involved in Treg
cell function. To do this, we generated Treg cell-specific GATA-3 deficient mice by
crossing Gata3fl/fl mice (Amsen et al., 2007) with mice bearing a BAC transgene encoding
both enhanced green fluorescence protein (EGFP) and Cre recombinase under the control of
Foxp3 promoter (Foxp3-EGFP-cre mice (Zhou et al., 2008), hereafter referred to as FGC
mice). In FGC mice, EGFP expression faithfully marks Foxp3-expressing Treg cells and
Cre-mediated gene deletion occurs specifically in Treg cells (Zhou et al., 2008).
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Although Gata-3fl/fl:FGC mice were born normally and matured to adulthood, they
spontaneously developed lymphadenopathy and splenomegaly by 16 weeks of age (data now
shown). In agreement with this observation, the total numbers of lymphocytes recovered
from the peripheral lymph-nodes (PLN) and spleens of Gata-3fl/fl:FGC mice were higher
compared to those from Gata-3fl/+:FGC littermates (Fig. 1a), although the distribution of T
cell populations in the thymus, spleen and peripheral lymph-nodes was normal and Treg
cells were generated in the thymus in Gata-3fl/fl:FGC mice (Supplementary Fig. S2). In
addition, histological analysis revealed dramatically increased lymphocytic infiltration in the
non-lymphoid organs, such as the lung, pancreas, lacrimal glands, and salivary glands of
Gata-3fl/fl:FGC mice (Fig. 1b), suggesting aberrant immune activation. We thus examined
the activation and differentiation status of T cells from Gata-3fl/fl:FGC mice. CD4+ Tn and
CD8+ T cell populations with an activated phenotype (CD62LlowCD44high) were increased
in Gata-3fl/fl:FGC mice compared to those in Gata-3fl/+:FGC littermates (Fig. 1c and
supplementary Fig. S2). In addition, interferon-γ (IFN-γ), interleukin-4 (IL-4) and IL-17
production by CD4+ Tn cells were increased in Gata-3fl/fl:FGC mice compared to
Gata-3fl/+:FGC littermates (Fig. 1d and 1e). Similarly, CD8+ T cells from Gata-3fl/fl:FGC
mice produced increased amounts of IFN-γ (Supplementary S2). Therefore, Treg cell-
specific GATA-3 deletion led to an inflammatory disorder in mice, associated with elevated
activation and effector function of T cells.
2. Treg cells lacking GATA-3 are defective in homeostasis
We then investigated how the Treg cell population was affected by GATA-3 deletion. First,
efficient and specific deletion of GATA-3 in Treg cells purified from Gata-3fl/fl:FGC mice
was confirmed (Fig. 2a). Initial characterization showed that the numbers of Treg cells were
not decreased but moderately increased in Gata-3fl/fl:FGC mice (Fig. 2b). Nevertheless, this
observation could be confounded by the inflammatory conditions existed in these mice
because Treg cell numbers may be abnormally up-regulated in the hosts with inflammation
(Kitoh et al., 2009; Liu et al., 2008; Rudra et al., 2009).
We therefore compared the ability of GATA-3-deficient and GATA-3-sufficient Treg cells
to repopulate the periphery in the same host. To this end, we generated mixed bone marrow
chimera by transferring a mixture of bone marrow cells from Gata-3fl/fl:FGC mice bearing
congenic marker CD45.2 and Gata-3fl/+:FGC mice bearing congenic marker CD45.1 into
irradiated recipient mice deficient in recombination-activating gene 1 (Rag1-/-). All chimeric
mice were grossly normal and showed no signs of inflammatory disorder (data not shown).
Accordingly, in the chimeric mice, CD4+ Tn and CD8+ T cells of both donor origins showed
naïve phenotype with minimal production of effector cytokines (Supplementary Fig. S3).
While total CD4+ T cells were derived equally from both donors, the majority (70-80%) of
Foxp3+ Treg cells were derived from GATA-3-sufficient donor. And only approximately
20% of Treg cells were derived from GATA-3-deficient donor (Fig. 2c), suggesting an
intrinsic defect in the homeostasis of GATA-3-deficient Treg cells. To confirm that
GATA-3-deficient Treg cells were indeed defective in homeostasis in the periphery, we
purified Treg cells from Gata-3fl/fl:FGC (CD45.2+) and Gata-3fl/+:FGC (CD45.1+) mice by
fluorescence activated cell sorting (FACS). Sorted cells were mixed at 1:1 ratio and then
transferred into Rag1-/- mice. Eight weeks after transfer, the contributions of different donor
cells to Foxp3+ Treg cell populations in the hosts were assessed. GATA-3-deficient Treg
cells were much less abundant than GATA-3-sufficient counterparts (Fig. 2d). Collectively,
these findings suggest that GATA-3-deficient Treg cells are intrinsically defective in the
homeostasis.
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3. Immune suppressive activity is impaired in Treg cells lacking GATA-3
We investigated what functions of Treg cells were affected by GATA-3 deletion. The
defining properties of Treg cells are being un-responsive to T cell receptor (TCR)
stimulation (anergy) in vitro and being able to suppress CD4+ Tn cell function in vivo and in
vitro (Sakaguchi, 2004). We found that GATA-3 deficient Treg cells remained anergic to
TCR stimulation, because Treg cells from Gata-3fl/fl:FGC mice did not proliferate in
response to TCR stimulation in culture (Fig. 3a). We then studied whether the immune
suppressive activity of GATA-3-deficient Treg cells was affected in vivo by using an
inflammatory bowel disease (IBD) model induced by transferring naïve CD4+ cells into
SCID mice (Powrie et al., 1993). Transferring wild-type naïve (CD25-CD45RBhigh) CD4+ T
cells alone elicited IBD in Rag1-/- recipient mice manifested by progressive weight loss (Fig.
3b). Co-transfer with wild-type Treg cells was able to prevent the weight loss (Fig. 3b). In
contrast, co-transfer with GATA-3-deficient Treg cells failed to stop naive T cell-elicited
weight loss in the recipient mice (Fig. 3b). This observation could be due to reduced
numbers of GATA-3-deficient Treg cells in the recipient mice and/or defective suppressive
activity of these cells. Further examination revealed that the numbers of Foxp3+ GATA-3-
deficient Treg cells recovered from the recipient mice were much lower than those of wild-
type Treg cells (Fig. 3c). To directly assess immune suppressive activity of GATA-3-
deficient Treg cells, we used an in vitro suppression assay and found that GATA-3-deficient
Treg cells showed impaired ability to suppress TCR-stimulated proliferation of co-existing
CD4+ Tn cells (Fig. 3d). Therefore, GATA-3 was required for intact immune suppressive
activities of Treg cells in vivo and in vitro.
4. GATA-3 deficient Treg cells gain the ability to produce Th17 cell cytokines
Treg cells normally do not produce effector cytokines. However, perturbation of Treg cell
function often leads to aberrant cytokine production by these cells (Gavin et al., 2007; Kitoh
et al., 2009; Oldenhove et al., 2009; Ouyang et al., 2010; Wan and Flavell, 2007). Our
finding that GATA-3 deletion resulted in defective Treg cell function prompted us to ask
whether GATA3-deficient Treg cells produced pro-inflammatory cytokines. While freshly
isolated GATA-3-deficient Treg cells produced minimal amounts of IFN-γ and IL-4, more
than 3% of these cells produced IL-17A, a defining cytokine for Th17 cells (Harrington et
al., 2005; Park et al., 2005). At least 3-fold more of IL-17A was produced by GATA-3 -
deficient than -sufficient Treg cells at both mRNA and protein levels (Fig. 4a and 4b). This
aberrant acquisition of a Th17 cell phenotype from GATA-3-deficient Treg cells was even
more pronounced in mice afflicted with IBD (Fig. 4c and 4d). Because the inflammatory
cytokine IL-6 promotes IL-17A production in activated Foxp3+ Treg cells in vitro (Xu et al.,
2007; Yang et al., 2008), we speculated that IL-6 driven IL-17A expression would be
enhanced in Treg cells with GATA-3 deletion. Indeed, upon TCR stimulation in the
presence of exogenous IL-6 alone or IL-6 plus transforming growth factor-β (TGF-β), a
notably higher percentage of GATA-3-deficient Foxp3+ Treg cells produced IL-17A than
that of GATA-3-sufficient Treg cells (Fig. 4e). Therefore, GATA-3-deficient Treg cells
acquired enhanced ability to produce Th17 cell cytokines.
5. The expression of Foxp3 and Treg cell signature genes is decreased in GATA-3 deficient
Treg cells
Aforementioned findings suggested that GATA-3 was essential for Treg cell function and
prompted us to investigate which factor critical for Treg cell function was affected by
GATA-3 deletion. We first noticed that EGFP expression, which reflected Foxp3 expression
at the transcription level in FGC mice, was consistently lower in Treg cells from
Gata-3fl/fl:FGC mice than from Gata-3fl/+:FGC mice (Fig. 5a). To directly assess Foxp3
mRNA expression, we sorted GATA-3 -deficient and -sufficient Treg cells from
Gata-3fl/fl:FGC and Gata-3fl/+:FGC mice respectively and detected Foxp3 expression by
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quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Indeed, the amount
of Foxp3 mRNA was decreased by approximately 50% upon GATA-3 deletion (Fig. 5b). In
addition, the amount of Foxp3 protein was reduced to a similar extent in GATA-3-deficient
Treg cells (Fig. 5c). Treg cell signature genes, such as CD25, CTLA-4 and GITR, are
important for Treg cell function (Sakaguchi, 2004). We then examined whether the
expression of these genes was affected by GATA-3 deletion. Compared to Treg cells from
Gata-3fl/+:FGC mice, Treg cells from Gata-3fl/fl:FGC mice consistently expressed less
CD25, CTLA-4 and GITR at both mRNA and protein levels (Fig. 5d and 5e). Similar
observation were made in mixed bone marrow chimera that was reconstituted with bone
marrow cells from Gata-3fl/fl:FGC mice (CD45.2+) and Gata-3fl/+:FGC mice (CD45.1+)
(Fig. 5f); GATA-3-deficient Treg cells expressed less amounts of Foxp3, CD25, CTLA-4
and GITR than those of GATA-3-suficient counterparts in the same host. Therefore,
GATA-3 deletion led to reduced expression of Foxp3 and Treg cell signature genes in Treg
cells.
6. GATA-3 binds to CNS2 of Foxp3 locus and promotes its activity
Foxp3 is central to controlling various aspects of Treg cell function. The observation that
GATA-3 deletion caused a decrease of Foxp3 expression (Fig. 5) prompted us to study the
mechanisms by which GATA-3 regulates Foxp3 expression. While reduced CD25
expression in GATA-3-deficient Treg cells can contribute to decreased Foxp3 expression
since IL-2 signaling is critical for Foxp3 expression (Fontenot et al., 2005; Rubtsov et al.,
2010), we nonetheless hypothesized that GATA-3 may also directly regulate Foxp3
expression. Using PROMO, a transcription factor binding site prediction program, we
identified putative GATA-3 binding sites in previously defined Foxp3 regulatory regions
(Fig. 6a). Four highly conserved non-coding DNA sequences (CNS) including promoter,
CNS1, CNS2 and CNS3 in Foxp3 locus have been identified (Long et al., 2009; Zheng et
al., 2010). CNS1 is critical for TGF-β-induced Foxp3 expression, CNS2 is important to
maintain Foxp3 expression in thymus-derived Treg cells, and CNS3 acts as a pioneer
element for Foxp3 expression. We first investigated whether GATA-3 bound to these
putative sites in Treg cells by performing chromatin immuno-precipitation (ChIP) assay. As
expected, we found enrichment of GATA-3 binding to the Th2 locus (positive control) (Lee
et al., 2006) but not the promoter region of Gmpr gene (negative control). Nuclear lysates
prepared from Treg and CD4+ Tn cells sorted from wild-type mice were subjected to ChIP
analysis. Enrichment of GATA-3 binding to different sites was determined by quantitative
PCR. GATA-3 showed minimal or no binding to the promoter, CNS1 and CNS3 regions of
Foxp3 locus in both Treg and CD4+ Tn cells (Fig. 6b). In contrast, a dramatic increase of
GATA-3 binding to CNS2 was observed only in Treg cells but not in CD4+ Tn cells,
suggesting that GATA-3 binds to and regulates CNS2 activity to control Foxp3 expression
specifically in Treg cells (Fig. 6b). To investigate if GATA-3 is able to regulate CNS2
activity, we utilized luciferase reporter assays. Luciferase reporter constructs containing
Foxp3 promoter alone or promoter plus CNS2 (Long et al., 2009) were transfected into
Jurkat T cells together with either a GATA-3-expressing construct or an empty construct
(control). While GATA-3 expression slightly enhanced the activity of Foxp3 promoter in the
absence of CNS2, it greatly promoted the activity of Foxp3 promoter in the presence of
CNS2 (Fig. 6c). This activity appeared to require direct binding of GATA-3, because
GATA-3 promoted activity was virtually abolished when a substitution mutation of the
GATA-3 binding site in CNS2 was created (Fig. 6d). Taken together, these findings suggest
that GATA-3 controls Foxp3 expression through binding to CNS2 to regulate the activity of
cis-acting elements of the Foxp3 gene.
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7. The combined function of GATA-3 and Foxp3 is essential for Foxp3 expression
Multiple transcription factors, including Foxp3 itself, were shown to be important for Foxp3
expression and Treg cell function (Gavin et al., 2007; Kerdiles et al., 2010; Kitoh et al.,
2009; Ouyang et al., 2010; Rudra et al., 2009; Zheng et al., 2010). Nevertheless, defects in a
single factor rendered incomplete abrogation of Treg cell population and/or function,
suggesting that transcription factors may act in combination and redundancy to control
Foxp3 expression and Treg cell function. Genome-wide studies to predict transcription
factor binding sites showed that Treg cell specific genes and Foxp3 dependent genes tend to
have binding sites for both GATA-3 and Foxp3 (Lee et al., 2010), indicating a functional
relationship between GATA-3 and Foxp3 in Treg cells. Because Foxp3 is critical for its own
expression (Gavin et al., 2007; Zheng et al., 2010) and we found that GATA-3 was
important for Foxp3 expression, we hypothesized that the combined function of GATA-3
and Foxp3 is essential to control Foxp3 expression and that defects in both GATA-3 and
Foxp3 would lead to drastic reduction of Treg cells.
To test this hypothesis, we first investigated whether GATA-3 remained bound to CNS2 of
Foxp3 locus in Treg cells isolated from FILIG mouse, a hypomorphic Foxp3 strain in which
Treg cells express greatly reduced Foxp3 and are marked by EGFP (Wan and Flavell, 2007).
A strong association of GATA-3 to CNS2 was detected only in Foxp3-expressing Treg cells
but not in CD4+ Tn cells purified from FILIG mice (Fig. 7a), suggesting that GATA-3 is
involved in Foxp3 expression in FILIG Treg cells. Indeed, by crossing Gata-3fl/fl:FGC mice
with FILIG mice, we found that the numbers of Foxp3-expressing Treg cells detected in
Gata-3fl/fl:FGC:FILIG mice were lower than in Gata-3fl/+:FGC:FILIG mice (Fig. 7b). A
closer examination revealed an incomplete deletion of GATA-3 in Treg cells purified from
Gata-3fl/fl:FGC:FILIG mice (Fig. 7c). Thus, Treg cells remained in Gata-3fl/fl:FGC:FILIG
mice were “escapees” that expressed GATA-3. Because the Cre expression reflects
endogenous Foxp3 expression in FGC mice (Zhou et al., 2008), the great reduction of Foxp3
expression in FILIG mice (Wan and Flavell, 2007) could result in insufficient Cre
expression and thus incomplete deletion of GATA-3 in Gata-3fl/fl:FGC:FILIG mice. To
circumvent this pitfall and to achieve efficient deletion of GATA-3 in FILIG Treg cells, we
bred Gata-3fl/fl:FILIG mice with CD4-Cre transgenic mice (Lee et al., 2001) to generate
Gata-3fl/fl:CD4cre:FILIG mice. Sufficient numbers of CD4+ T cells were recovered from
Gata-3fl/fl:CD4cre:FILIG mice. In addition, efficient deletion of GATA-3 in these cells was
confirmed (Supplementary Fig. S4). While more than 20% of GATA-3-sufficient CD4+
FILIG cells expressed Foxp3, virtually no GATA-3-deficient CD4+ FILIG cells expressed
Foxp3 (Fig. 7d). Therefore, defective function of both GATA-3 and Foxp3 led to ablation of
Treg cells, suggesting that the combined function of GATA-3 and Foxp3 is essential for
Foxp3 expression.
Discussion
This study revealed an indispensible role of GATA-3 in regulating Treg cell function and
immune tolerance. Deletion of GATA-3 specifically in Treg cells resulted in an
inflammatory syndrome in mice that can be ascribed to defective function of Treg cells. In
addition, we found that GATA-3 controlled Foxp3 expression. GATA-3-deficient Treg cells
expressed reduced amounts of Foxp3. GATA-3 bound to the regulatory regions of Foxp3
locus and promoted the activity of cis-acting elements of Foxp3 gene. Moreover, we
demonstrated that the combined function of GATA-3 and Foxp3 was vital for Foxp3
expression in Treg cells. This study provides insights into the modulation of Treg cell
function and sheds lights on how autoimmunity and inflammatory diseases may be
controlled.
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GATA-3 is a member of GATA-binding protein family consisting of six members
(GATA-1-6) that interact with the GATA DNA sequence. GATA-3 regulates an array of
biological processes including development, differentiation and tumorigenesis (Pandolfi et
al., 1995; Pei et al., 2009). In particular, GATA-3 is critically involved in immune
regulation. GATA-3 is highly expressed by Th2 cells and is required for Th2 cell
differentiation (Zheng and Flavell, 1997; Zhu et al., 2004). In addition, GATA-3 is essential
for T cell development (Pai et al., 2003). Moreover, it is important for the function of NK
cells (Samson et al., 2003). Therefore, GATA-3 exerts diverse functions to control immune
response in a cell type specific manner. Nevertheless, the understanding of how GATA-3
regulates immune function is far from complete. Indeed, this study unveiled a function of
GATA-3 in controlling Treg cell function. Such a function of GATA-3 is vital for self-
tolerance and immune homeostasis, because when GATA-3 was deleted in Treg cells, mice
spontaneously developed an inflammatory disorder. This finding can have broad
implications. Th1 response is important for clearing pathogens and also for causing severe
autoimmune diseases, situations where Treg cell function is often tempered (Caretto et al.,
2010; Oldenhove et al., 2009). Th1 cell polarizing condition antagonizes GATA-3
expression in non-Treg cells (Szabo et al., 2003). Similarly, we found that Th1 cell
polarizing condition also triggers the down-regulation of GATA-3 in Treg cells. It is
therefore conceivable that the strong Th1 response during pathogen clearance and
inflammation will lead to GATA-3 down-regulation in Treg cells, which may in turn
contribute to the reduced function of these cells. In addition, we have demonstrated that
GATA-3-deficient Treg cells showed enhanced ability to produce inflammatory cytokines,
indicating that GATA-3 down-regulation under inflammatory conditions could allow Treg
cells to acquire effector functions that contribute to inflammation. Our study therefore
suggests that GATA-3 expression in Treg cells is important for the modulation of Treg cell
function and immune response, and thus needs to be considered in order to fully understand
how protective (to clear pathogen) and pathogenic (to cause autoimmunity and inflammatory
disease) immune responses are controlled.
Treg cells are central to controlling immune tolerance and immune homeostasis. Foxp3 is
recognized as a single gene determinant essential for Treg cell function. Perturbations of
Foxp3 expression, even slight, often lead to impaired Treg cell function and are associated
with various inflammatory diseases and autoimmunity. Therefore, in order to understand
immune-tolerance, how Foxp3 transcription is controlled is a critical question under
intensive investigation. Many factors including Runx-CBFβ complex, NFκB, Foxp3,
FOXO1 and FOXO3, were shown to be important for Foxp3 expression (Gavin et al., 2007;
Kerdiles et al., 2010; Kitoh et al., 2009; Long et al., 2009; Ouyang et al., 2010; Rudra et al.,
2009; Zheng et al., 2010). Nonetheless, deletion of any one of these genes causes incomplete
abrogation of Foxp3 expression. These findings not only underscore the vital importance of
maintaining certain amounts of Foxp3 expression but also implicate that multiple factors are
involved in promoting Foxp3 expression in a combinatorial and somewhat redundant
manner. Indeed, combined deficiency of certain set of genes, such as FOXO1 and FOXO3,
results in much more drastic defect in Treg cells than any one gene deficiency achieved
(Kerdiles et al., 2010; Ouyang et al., 2010). Similarly, our results demonstrated that,
although impaired function of GATA-3 or Foxp3 alone caused decrease of Foxp3
expression, defects in both GATA-3 and Foxp3 led to ablation of Foxp3 expression,
suggesting that GATA-3 and Foxp3 control Foxp3 expression in combination. Therefore,
while we are investigating how a single factor is involved in controlling Foxp3 expression,
we also need to consider how different factors function together to control Foxp3 expression
and Treg cell function.
As a transcription factor, GATA-3 exerts its function mainly through DNA binding. It is
therefore likely that cell-type specific function of GATA-3 is mediated through its binding
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to different sets of loci in different cell types. To support this notion, we found that, in non-
Treg cells, GATA-3 bound to Th2 locus but not Foxp3 locus. However, in Treg cells,
GATA-3 bound to both Th2 locus and CNS2 of Foxp3 locus. Inter-chromosomal interaction
has been proposed to regulate activities of cis-acting elements on different chromosomes
(Spilianakis et al., 2005). Such inter-chromosomal interactions may be mediated through
protein complexes containing specific transcription factors. The observation that GATA-3
bound to both Foxp3 and Th2 loci in Treg cells suggests a potential physical interaction and
mutual regulation between Foxp3 and Th2 loci in Treg cells, an issue that warrants further
investigation to elucidate the mutual regulation between Th2 and Treg cells. Although we
have found that GATA-3 bound to CNS2 but not CNS1 (a site modulating Foxp3 expression
in TGF-β-induced Treg cells (Zheng et al., 2010)) of Foxp3 locus in thymic-derived Treg
cells, consensus GATA-3 binding sites were identified in CNS1 suggesting that GATA-3
may be also involved in regulating Foxp3 expression in TGF-β-induced Treg cells. Th2 cell
polarizing condition was shown to antagonize TGF-β-driven Foxp3 expression and to
promote Th9 cell differentiation (Dardalhon et al., 2008; Veldhoen et al., 2008), a process
that may involve GATA-3 (Mantel et al., 2007). Further investigation is therefore needed to




Foxp3-GFP-Cre (FGC) mice were purchased from Jackson laboratory and have been
backcrossed into C57BL/6 background for more than 5 generations. GATA-3fl/fl, CD4-Cre,
FILIG, Rag1-/- and CD45.1 congenic mice were on C57BL/6 background. All mice were
housed and bred in specific pathogen-free conditions in the animal facility at the University
of North Carolina at Chapel Hill. All mouse experiments were approved by Institution
Animal Care and Use Committee of the University of North Carolina.
2. Flow cytometric analysis and cell sorting
Lymphocytes were isolated from the various organs (as described) of age and sex matched
mice of 8-16 weeks of age. Fluorescence-conjugated antibodies for CD4, CD8, CD25,
CD44, CD62L, GITR, CD45.1, CD45.2, IFN-γ, IL-4, IL-17, Foxp3 (eBioscience) and
CTLA-4 (BD Bioscience) were purchased. Surface and Intracellular staining was performed
per manufacturer’s protocols. For intracellular cytokine staining, lymphocytes were
stimulated with 50 ng/ml of phorobol 12-myristate 13-acetate (PMA) and 1 μM of
ionomycin for 3-4 hours in the presence of Brefeldin A. Stained cells were analyzed on a
LSRII station (BD Biosciences) or sorted on Moflow cell sorter (Dako cytomation,
Beckman Coulter).
3. In vitro cell proliferation and suppression assay
CD4+GFP+ Treg cells (suppressor) and CD4+GFP- non-Treg cells (responder) were sorted.
To assess Treg cell proliferation in vitro, 2×104 sorted Treg cells were labeled with
carboxyfluorescein diacetate succinimidyl ester (CFSE) and stimulated with soluble CD3
antibody (1μg/ml) in the presence of 1×105 irradiated (3000 cGy) T-cell depleted
splenocytes as antigen presenting cells (APC). Cell proliferation was assessed by CFSE
dilution detected by flow-cytometric analysis 72 hours post stimulation. To assess the
efficacy of Treg cell mediated immune suppression in vitro, 2×104 sorted responder T cells
were labeled with CFSE and mixed with varying amounts (as indicated) of Treg suppressor
cells. Cell mixtures were stimulated with soluble CD3 antibody (1μg/ml) in the presence of
1×105 irradiated (3000 cGy) T-cell depleted splenocytes as APC. The proliferation of
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responder cells was assessed by CFSE dilution detected by flow-cytometric analysis 72
hours post stimulation.
4. Luciferase reporter assay
PGL4-Pro and PGL4-Pro-CNS2 luciferase reporter constructs were kindly provided by Dr.
S. Ghosh (Columbia University). Substitution mutation of GATA-3-binding site at CNS2
was created with Quickchange Mutagenesis kit (Agilent Technologies). Jurkat T cells were
transfected by electroporation with 5μg of reporter plasmid together with 5μg of GATA-3
expressing plasmids. 1μg of pRL-TK plasmid was also co-transfected serving as an internal
control. Firefly and Renilla Luciferase activities were determined with a dual-reporter assay
kit (Promega) 36 hours post transfection.
5. Adoptive transfer assay, Treg cell-mediated protection of naïve CD4+ T-cell-elicited IBD
assay, and bone marrow transplantation assay
To determine the ability of Treg cells to be maintained in the periphery, GATA-3-sufficient
and GATA-3-deficient CD4+GFP+ Treg cells bearing different CD45 congenic markers
were sorted. 1×105 sorted Treg cells were co-transferred into Rag1-/- recipients via retro-
orbital injection. The contribution of each donor to the Treg cell population recovered in the
hosts was determined 8 weeks post transfer. To assess Treg cell-mediated protection of
naïve T-cell-elicited IBD in vivo, 1×105 sorted Treg cells were mixed with 2×105 naive
(CD25-CD45RBhigh) CD4+ T cells sorted from wild-type C57BL/6 mice. Cell mixture was
transferred into Rag1-/- via retro-orbital injection. As control, 2×105 naïve CD4+ T cells
were also transferred alone into Rag1-/- mice. To monitor IBD development, body weight of
the recipient mice was monitored weekly after the transfer. Recipient mice were euthanized
8 weeks after transfer. T cells from these mice were harvested and subjected to
immunological analysis. To create mixed bone marrow chimera, bone marrow cells were
isolated from the femur bones of Gata3fl/fl:FGC or Gata3fl/+:FGC mice bearing different
CD45 congenic markers. 1×106 bone marrow cells from each donor were mixed and
transferred into irradiated (500 cGy) Rag1-/- mice. The contribution of each donor to Treg
cell population in the recipients was determined 8 weeks after transfer.
6. Chromatin Immuno-precipitation (ChIP) assay
ChIP assay was performed per Upstate Biotechnology’s protocol. Briefly, cells were cross-
linked by 1% formaldehyde and lysed in lysis buffer. The lysates were sonicated with a
Bioruptor sonicator to shear genomic DNA into 200-500 bp fragments. Chromatin prepared
from 2×106 CD4+GFP+ Treg cells and CD4+GFP- Tn cells were subjected to immuno-
precipitation overnight at 4°C using goat anti-GATA-3 (D-16, sc-22206, Santa Cruz) or
normal goat IgG (sc-2028, Santa Cruz) antibodies. Quantitative real-time PCR was
performed to determine the relative abundance of target DNA. Specific primers for analysis
of GATA-3 binding to Foxp3 and other target loci are listed in Supplementary Table S1.
7. Statistical analysis
Data from at least three sets of samples were used for statistical analysis. Statistical
significance was calculated by Student’s t-test. A P value of less than 0.05 was considered
significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1. GATA-3 deficiency in Treg cells results in a spontaneous immune disorder.
2. GATA-3 null Treg cells are defective in homeostasis and display aberrant
function.
3. GATA-3 binds to the Foxp3 locus and regulates its transcription.
4. The combined function of Foxp3 and GATA-3 is vital for Foxp3 expression.
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Fig. 1. GATA-3 deletion in Treg cells leads to an inflammatory disorder in mice
1a, The numbers of lymphocytes in the PLN and spleens from Gata3fl/fl:FGC and
Gata3fl/+:FGC littermates. Data are Means ± s.d. of five mice. (*, P<0.05). 1b, Histological
analysis of lymphocytic infiltration in the lung, pancreas, lacrimal gland and salivary gland
of indicated mice by H&E staining. 1c, Expression of CD44 and CD62L on CD4+Foxp3-
(Tn) cells from the lymph nodes and spleens of Gata3fl/fl:FGC mice and Gata3fl/+:FGC
littermates. Number in each quadrant showed the percentage of each population. Data
represent at least four independent experiments. 1d, IFN-γ, IL-4 and IL-17 expression by
CD4+Foxp3- (Tn) cells from the PLNs of Gata3fl/fl:FGC mice and Gata3fl/+:FGC
littermates. Number in each quadrant showed the percentage of each population. Results are
representative of at least four experiments. 1e, Relative mRNA expression amounts of IFN-
γ, IL-4 and IL-17 in sorted CD4+GFP- Tn cells from Gata3fl/fl:FGC mice and
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Gata3fl/+:FGC littermates. Means ± s.d. of triplicates done in one experiments
representative of three are shown.
See also Fig. S2.
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Fig. 2. Intrinsic defects of GATA-3-deficient Tregs in the peripheral homeostasis
2a, Efficient GATA-3 deletion specifically in Treg cells from Gata3fl/fl:FGC mice. CD4+
Tn cells (CD4+GFP-) and Treg cells (CD4+GFP+) were sorted from Gata3fl/+:FGC and
Gata3fl/fl:FGC mice. mRNA and protein expression of GATA-3 in each population was
assessed by qRT-PCR and immuno-blotting respectively. Results for qRT-PCR were Means
± s.d. of triplicates done in one experiment representative of three. Results for immuno-
blotting were representative of at least three experiments. 2b, The percentages of Foxp3+
Treg cells in CD4 T cells from PLNs and spleens of Gata3fl/+:FGC (open bars) and
Gata3fl/fl:FGC (solid bars) mice. Means ± s.d. of four experiments are shown. 2c, Mixed
bone marrow chimera were created by transferring equal numbers of bone marrow cells
from Gata3fl/+:FGC (CD45.1+) and Gata3fl/fl:FGC (CD45.2+) mice into sub-lethally
irradiated Rag1-/- mice. The contributions of cells originated from Gata3fl/+:FGC (open
bars) and Gata3fl/fl:FGC (solid bars) bone marrow cells to CD4+ T cell and Foxp3+ Treg
cell populations in reconstituted hosts were determined. Means ± s.d. of six mice from one
experiment representative of two are shown (NS, Non-significant. **, P<0.01). 2d, GFP+
Treg cells were sorted from Gata3fl/+:FGC (CD45.1+) and Gata3fl/fl:FGC (CD45.2+) mice,
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mixed at a ratio of 1:1 and then transferred into Rag1-/- mice. Eight weeks after transfer,
Foxp3+ Treg cells from different donors were detected by Foxp3 and CD45 co-staining as
shown in left plot. The contributions of each donor origin to Treg cell population in the
recipients were determined. Means ± s.d. of five mice from one experiment representative of
two are shown (**, P<0.01).
See also Fig. S3
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Fig. 3. Immune suppressive activity of Treg cells is impaired in the absence of GATA-3
3a, GATA-3-deficient Treg cells remained anergic in vitro. GFP+ Treg cells were sorted
from Gata3fl/fl:FGC (Gata3-, dashed line) and Gata3fl/+:FGC (Gata3+, solid line) mice. As
a control, GFP- CD4+ Tn (shaded) cells were sorted from Gata3fl/+:FGC mice. Sorted cells
were labeled with CFSE and stimulated with soluble anti-CD3 in the presence of irradiated
APC. Cell proliferation was assessed by CFSE dilution 72 hours after TCR stimulation in
vitro. 3b, GATA-3-deficient Treg cells failed to suppress T cell function in vivo. Rag1-/-
mice were transferred with 2×105 CD4+CD25-CD45RBhigh T cells sorted from wild-type
C57BL/6 mice alone (dotted line), or together with 1×105 of GFP+ Treg cells sorted from
Gata3fl/fl:FGC mice (dashed line) or from Gata3fl/+:FGC mice (solid line). Body weight of
recipient mice was monitored weekly for 8 weeks after transfer. The percentage of body
weight change was calculated and plotted. Means ± s.e.m of five mice in one experiment
representative of two are shown (**, P<0.01). 3c, The percentages (indicated by the
numbers above the brackets) of Foxp3+ Treg cells in CD4+ T cells recovered from the
peripheral lymph-nodes (PLN), mesenteric lymph-nodes (MLN) and spleens of recipient
mice were determined at the end of experiments described in Fig. 3b. Means ± s.d. of five
mice in one experiment representative of two are shown. 3d, GATA-3-deficient Treg cells
were defective in suppressing T cell function in vitro. CD4+CD25-CD45RBhigh responder T
(Tresp.) cells were sorted from wild-type C57BL/6 mice and labeled with CFSE. Labeled
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responder T cells were then either cultured alone or mixed with varying amounts (as
indicated) of GFP+ Treg cells sorted from Gata3fl/fl:FGC or Gata3fl/+:FGC mice. Cell
mixtures were stimulated with soluble anti-CD3 in the presence of irradiated APC. The
proliferation of responder T cells was assessed by CFSE dilution as shown in left plots. The
division-index of responder T cells was determined by FlowJo software and plotted (right
panel). Means ± s.d. of triplicate done in one experiments representative of two are shown.
(*, P<0.05).
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Fig. 4. Th17 cytokine production by GATA-3-deficient Treg cells
4a and 4b, GFP+ Treg cells were purified from Gata3fl/fl:FGC and Gata3fl/+:FGC mice.
Protein expression of IFN-γ, IL-4 and IL-17A in sorted Treg cells was assessed by
intracellular staining. The numbers in each quadrant indicate the percentage of relevant
population. Representative results of at least five experiments are shown (4a). Relative
mRNA amounts of IL-17A, IL-21, IFN-γ, Rorc and T-bet in sorted Treg cells were
determined by qRT-PCR. Means ± s.d. of triplicates done in one experiment representative
of three are shown (4b). 4c and 4d, At the end of IBD experiment described in Fig. 3b,
CD4+ T cells were recovered from mesenteric lymph-nodes (MLN) and spleens of the
recipient mice. Protein expression of IL-17A and IFN-γ in recovered Foxp3+ Treg cells was
determined by intracellular staining. Representative results of three experiments are shown
(4c). Relative mRNA amounts of IL-17A, IL-21, IFN-γ, Rorc and T-bet in sorted GFP+ Treg
cells from the spleens were determined by qRT-PCR. Means ± s.d. of triplicates done in one
experiment representative of three are shown (4d). 4e. GFP+ Treg cells were sorted from
Gata3fl/fl:FGC and Gata3fl/+:FGC mice and then stimulated in vitro with anti-CD3 and anti-
CD28 in the presence of IL-6 (40ng/ml) or IL-6 (40ng/ml) + TGF-β (2ng/ml). Four days
after stimulation, IL-17A production in Foxp3+ cells was assessed. Results representative of
three experiments are shown.
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Fig. 5. Decreased expression of Foxp3 and Treg cell signature genes in GATA-3-deficient Treg
cells
5a, EGFP expression of gated CD4+GFP+ Treg cells from PLNs and spleens of
Gata3fl/fl:FGC (dash lines) and Gata3fl/+:FGC (solid lines) mice. Mean fluorescence
intensity (MFI) of EGFP is also shown as Means ± s.d. of the results from three mice. 5b,
Quantitative RT-PCR analysis of Foxp3 mRNA in CD4+GFP- (Tn) and CD4+GFP+ (Treg)
cells sorted from Gata3fl/fl:FGC (solid bars) and Gata3fl/+:FGC (open bars) mice. Means ±
s.d. of triplicates done in one experiment representative of at least four experiments are
shown. 5c, Flow cytometric analysis of Foxp3 expression in CD4+ T cells in PLNs and
spleens of Gata3fl/fl:FGC (dashed lines) and Gata3fl/+:FGC (solid lines) mice. The
percentages of Foxp3+ cells and MFI of Foxp3 staining in Foxp3+ cells are also shown. 5d,
Relative mRNA amounts of CD25, CTLA-4 and GITR in GFP+ Treg cells sorted from
Gata3fl/fl:FGC (solid bars) and Gata3fl/+:FGC (open bars) mice. Means ± s.d. of triplicates
done in one experiments representative of four are shown. 5e, The expression of CD25,
CTLA-4 and GITR on GFP+ Treg cells from Gata3fl/fl:FGC (dashed lines) and
Gata3fl/+:FGC (solid lines) mice were assessed by flow cytometric analysis. MFIs are
shown as Means ± s.d. of three mice. 5f, At the end of mixed bone marrow chimera
experiments described in Fig. 2c, the expression of Foxp3, CD25, CTLA-4 and GITR in
GFP+ Treg cells originated from Gata3fl/fl:FGC (dashed lines) or Gata3fl/+:FGC (solid
lines) donors were determined by flow cytometric analysis and compared. Results described
in this figure are representative of at least three experiments unless stated otherwise.
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Fig. 6. GATA-3 bound to CNS2 of Foxp3 locus and promoted its activity
6a, An illustration of putative GATA-3 binding sites in the Foxp3 promoter (Pro), CNS1,
CNS2 and CNS3. The numbers denote relative positions to the transcription start site. Exons
are marked by filled boxes. 6b, ChIP-coupled quantitative PCR analysis of GATA-3 binding
to Foxp3 regulatory regions in sorted GFP-CD4+ Tn cells and GFP+ Treg cells purified from
FGC mice. Normal IgG and anti-GATA-3 were used for immuno-precipitation assays.
Gmpr locus was used as a negative control and Th2 locus was used as a positive control.
Enrichment of GATA-3 binding to each locus was determined. Means ± s.d. of triplicates
done in one experiment representative of at least three are shown. 6c and 6d, Luciferase
reporter assays. Reporter constructs of PGL4-basic, PGL4 linked with Foxp3 promoter
(PGL4-Pro), or PGL4 linked with Foxp3 promoter and CNS2 (PGL4-Pro-CNS2) were
transfected into Jurkat T cells together with a GATA-3-expressing plasmid (+) or an empty
plasmid (-) (6c). PGL4-Pro-CNS2 reporter constructs containing wild-type CNS2 (WT-
CNS2) or containing CNS2 with a substitute mutation of GATA-3 binding site (Gata3mut-
CNS2) were transfected into Jurkat T cells together with a GATA-3-expressing plasmid (+)
or an empty plasmid (-) (6d). In 6c and 6d, a Renilla luciferase vector (pRL-TK) was co-
transfected as internal controls. Transfected cells were cultured for 36 hr before relative
luciferase units were determined. Means ± s.d. of triplicates done in one experiment
representative of at least three are shown. (**, P<0.01).
See also Table S1.
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Fig. 7. The combined function of GATA-3 and Foxp3 was essential for Foxp3 expression
7a, ChIP-coupled quantitative PCR analysis of GATA-3 binding to CNS2 of Foxp3 locus in
sorted GFP-CD4+ Tn cells and GFP+ Treg cells from FILIG mice. Normal IgG and anti-
GATA-3 were used for immuno-precipitation assays. Gmpr locus was used as a negative
control and Th2 locus was used as a positive control. Enrichment of GATA-3 binding to
each locus was determined. Means ± s.d. of triplicates done in one experiment representative
of three are shown. 7b, The percentages of Foxp3+ Treg cells in the CD4+ T cells isolated
from PLN and spleens of Gata3fl/+:FGC:FILIG and Gata3fl/fl:FGC:FILIG mice. Means ±
s.d. of four mice are shown. (**, P<0.01). 7c, GATA-3 expression in GFP-CD4+ Tn and
GFP+ Treg cells sorted from Gata3fl/+:FGC:FILIG and Gata3fl/fl:FGC:FILIG mice. mRNA
expression of GATA-3 in sorted cells were assessed by quantitative RT-PCR (left panel).
Means ± s.d. of triplicates done in one experiment representative of three are shown. In
addition, protein expression of GATA-3 in sorted cells was assessed by immuno-blotting
(right panels). Results are representative of three experiments. 7d, Foxp3-expressing Treg
cells in the PLNs of Gata3fl/+:CD4cre:FILIG and Gata3fl/fl:CD4cre:FILIG mice were
detected based on GFP and Foxp3 expression. The percentages of Foxp3+ cells were
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determined (shown above the brackets). Representative results from at least three
experiments are shown.
See also Fig. S4
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